tykhr
sign in
free sign up
Protalix Biotherapeutics Inc
Biotechnology
Healthcare
PLX
76.61 M shares
NYSE MKT US
traded
23 Sep 2025
listed
no
open
2.01
52 week high
3.07
high
2.12
52 week low
0.00
low
1.96
growth
78.18 %
previous Close
2.04
P/E ratio
market cap
118 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
-100.00 %
net profit margin
0.00 %
35.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top